Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Windtree Therapeutics Inc as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- No complete 13F data for Q4 2020
- Shares held
- 1.11M
- No complete 13F data for Q4 2020
- Total value
- $2.72M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting WINT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 5 | $8.75K |
| Q1 2025 | 5 | $57.0K |
| Q4 2024 | 15 | $108.7K |
| Q3 2024 | 8 | $389.7K |
| Q2 2024 | 5 | $4.87K |
| Q1 2024 | 9 | $238.8K |
| Q4 2023 | 12 | $194.1K |
| Q3 2023 | 12 | $197.7K |
| Q2 2023 | 12 | $151.7K |
| Q1 2023 | 9 | $12.8K |
| Q4 2022 | 27 | $276.6K |
| Q3 2022 | 27 | $518.7K |
| Q2 2022 | 25 | $664.4K |
| Q1 2022 | 27 | $1.76M |
| Q4 2021 | 26 | $2.72M |
| Q3 2021 | 19 | $3.02M |
| Q2 2021 | 27 | $3.94M |
| Q1 2021 | 21 | $2.72M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Windtree Therapeutics Inc.
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 539,329 | $1.32M | 0.00% | – | – |
| Kepos Capital LP | 165,000 | $404.0K | 0.03% | – | – |
| Millennium Management LLC | 79,769 | $195.0K | 0.00% | – | – |
| Citadel Advisors LLC | 66,035 | $162.0K | 0.00% | – | – |
| PVG Asset Management Corp | 63,795 | $156.3K | 0.50% | – | – |
| Northern Trust Corp | 50,743 | $125.0K | 0.00% | – | – |
| Affinity Asset Advisors, LLC | 42,847 | $105.0K | 0.05% | – | – |
| Envestnet Asset Management Inc | 36,334 | $89.0K | 0.00% | – | – |
| HRT Financial LP | 23,365 | $57.0K | 0.00% | – | – |
| Deerfield Management Company, L.P. (Series C) | 20,148 | $49.0K | 0.00% | – | – |
| Renaissance Technologies LLC | 11,600 | $28.0K | 0.00% | – | – |
| Advisor Group Holdings, Inc. | 4,925 | $12.0K | 0.00% | – | – |
| Sowell Financial Services LLC | 4,137 | $9.00K | 0.00% | – | – |
| UBS Group AG | 1,224 | $3.00K | 0.00% | – | – |
| Bank of America Corp | 22 | $0 | 0.00% | – | – |
| Wells Fargo & Company | 33 | $0 | 0.00% | – | – |
| Morgan Stanley | 1 | $0 | 0.00% | – | – |
| Gradient Investments LLC | 23 | $0 | 0.00% | – | – |
| MCF Advisors LLC | 20 | $0 | 0.00% | – | – |
| IFP Advisors, Inc | 5 | $0 | 0.00% | – | – |
| Parallel Advisors, LLC | 11 | $0 | 0.00% | – | – |